AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 168 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $250,200 | -30.2% | 180,000 | 0.0% | 0.04% | -32.8% |
| Q4 2022 | $358,200 | -1.6% | 180,000 | 0.0% | 0.06% | -7.9% |
| Q3 2022 | $364,000 | -36.4% | 180,000 | 0.0% | 0.06% | -36.4% |
| Q2 2022 | $572,000 | -23.8% | 180,000 | 0.0% | 0.10% | -32.2% |
| Q1 2022 | $751,000 | -12.9% | 180,000 | 0.0% | 0.15% | -22.8% |
| Q4 2021 | $862,000 | -10.3% | 180,000 | 0.0% | 0.19% | -10.8% |
| Q3 2021 | $961,000 | +4.2% | 180,000 | 0.0% | 0.21% | +11.0% |
| Q2 2021 | $922,000 | -23.9% | 180,000 | 0.0% | 0.19% | -23.3% |
| Q1 2021 | $1,211,000 | +115.5% | 180,000 | +46.3% | 0.25% | +69.4% |
| Q4 2020 | $562,000 | +41.9% | 123,000 | +20.6% | 0.15% | +40.0% |
| Q3 2020 | $396,000 | -85.7% | 102,000 | -18.4% | 0.10% | -86.9% |
| Q3 2018 | $2,774,000 | -15.5% | 125,000 | -37.5% | 0.80% | -8.9% |
| Q2 2018 | $3,282,000 | – | 200,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $102,442,000 | 9.84% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $77,176,000 | 1.36% |
| Sivik Global Healthcare LLC | 600,000 | $2,856,000 | 0.95% |
| THB ASSET MANAGEMENT | 651,150 | $3,099,000 | 0.90% |
| Eversept Partners, LP | 886,587 | $4,220,154 | 0.58% |
| Spark Investment Management LLC | 30,100 | $143,000 | 0.52% |
| GLOBEFLEX CAPITAL L P | 240,680 | $1,146,000 | 0.29% |
| Alambic Investment Management, L.P. | 19,493 | $93,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 49,901 | $238,000 | 0.13% |
| C M BIDWELL & ASSOCIATES LTD | 29,550 | $141,000 | 0.13% |